Correlation Between Walker Dunlop and Bellerophon Therapeutics
Can any of the company-specific risk be diversified away by investing in both Walker Dunlop and Bellerophon Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Walker Dunlop and Bellerophon Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Walker Dunlop and Bellerophon Therapeutics, you can compare the effects of market volatilities on Walker Dunlop and Bellerophon Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Walker Dunlop with a short position of Bellerophon Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Walker Dunlop and Bellerophon Therapeutics.
Diversification Opportunities for Walker Dunlop and Bellerophon Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Walker and Bellerophon is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Walker Dunlop and Bellerophon Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bellerophon Therapeutics and Walker Dunlop is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Walker Dunlop are associated (or correlated) with Bellerophon Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bellerophon Therapeutics has no effect on the direction of Walker Dunlop i.e., Walker Dunlop and Bellerophon Therapeutics go up and down completely randomly.
Pair Corralation between Walker Dunlop and Bellerophon Therapeutics
If you would invest 7,406 in Walker Dunlop on December 5, 2024 and sell it today you would earn a total of 831.00 from holding Walker Dunlop or generate 11.22% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Walker Dunlop vs. Bellerophon Therapeutics
Performance |
| Timeline |
| Walker Dunlop |
| Bellerophon Therapeutics |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Walker Dunlop and Bellerophon Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Walker Dunlop and Bellerophon Therapeutics
The main advantage of trading using opposite Walker Dunlop and Bellerophon Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Walker Dunlop position performs unexpectedly, Bellerophon Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bellerophon Therapeutics will offset losses from the drop in Bellerophon Therapeutics' long position.| Walker Dunlop vs. Mr Cooper Group | ||
| Walker Dunlop vs. Velocity Financial Llc | ||
| Walker Dunlop vs. Security National Financial | ||
| Walker Dunlop vs. Encore Capital Group |
| Bellerophon Therapeutics vs. Bio Path Holdings | ||
| Bellerophon Therapeutics vs. Capricor Therapeutics | ||
| Bellerophon Therapeutics vs. NextCure | ||
| Bellerophon Therapeutics vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |